Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis

Title: Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis

Volume: 6 Issue: 3

Author(s): Zhuang Liu, Zhi-hua Yin, Hui-ying Liang, Zhi-fang Jia and Bao-sen Zhou

Affiliation:

Keywords: Chlamydia pneumoniae, lung cancer, meta-analysis

Abstract: To evaluate the relationship between Chlamydia pneumoniae infection and lung cancer, we conducted a metaanalysis of studies comparing the antibodies of C. pneumoniae between lung cancer patients and controls. The random-effects model or fixed-effects model was used according to the results of heterogeneity tests. Total, 8 studies with 1602 cases and 1734 controls were included. The analysis showed that the pooled OR of the association between C. pneumoniae IgA and lung cancer was 1.82 (95% CI, 1.21-2.74), while the association between C. pneumoniae IgG and lung cancer was 1.77 (95% CI, 1.13-2.78). Thus, statistically significant differences were observed between C. pneumoniae antibodies and lung cancer. This meta-analysis suggests that C. pneumoniae infection may be a potential risk factor for lung cancer.

Cite this article as:

Liu Zhuang, Yin Zhi-hua, Liang Hui-ying, Jia Zhi-fang and Zhou Bao-sen, Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526111